Correlation Between Quest PharmaTech and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Quest PharmaTech and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest PharmaTech and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quest PharmaTech and AN2 Therapeutics, you can compare the effects of market volatilities on Quest PharmaTech and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest PharmaTech with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest PharmaTech and AN2 Therapeutics.
Diversification Opportunities for Quest PharmaTech and AN2 Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Quest and AN2 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quest PharmaTech and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Quest PharmaTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest PharmaTech are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Quest PharmaTech i.e., Quest PharmaTech and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Quest PharmaTech and AN2 Therapeutics
Assuming the 90 days horizon Quest PharmaTech is expected to under-perform the AN2 Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Quest PharmaTech is 1.9 times less risky than AN2 Therapeutics. The pink sheet trades about -0.07 of its potential returns per unit of risk. The AN2 Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 925.00 in AN2 Therapeutics on September 14, 2024 and sell it today you would lose (780.50) from holding AN2 Therapeutics or give up 84.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Quest PharmaTech vs. AN2 Therapeutics
Performance |
| Timeline |
| Quest PharmaTech |
| AN2 Therapeutics |
Quest PharmaTech and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quest PharmaTech and AN2 Therapeutics
The main advantage of trading using opposite Quest PharmaTech and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest PharmaTech position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Quest PharmaTech vs. Coya Therapeutics, Common | Quest PharmaTech vs. Cue Biopharma | Quest PharmaTech vs. Lantern Pharma | Quest PharmaTech vs. Fennec Pharmaceuticals |
| AN2 Therapeutics vs. Puma Biotechnology | AN2 Therapeutics vs. Iovance Biotherapeutics | AN2 Therapeutics vs. Day One Biopharmaceuticals | AN2 Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |